Exicure reports Q3 results
Source: SeekingAlpha
2025-11-10 07:21:34 ET
More on Exicure
Read the full article on Seeking Alpha
For further details see:
Exicure reports Q3 results
Exicure Inc.
NASDAQ: XCUR
XCUR Trading
0.99% G/L:
$4.07 Last:
4,566 Volume:
$4.02 Open:
XCUR Latest News
February 05, 2026 07:00:00 am
Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant
January 21, 2026 07:00:00 am
Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings
December 09, 2025 10:09:02 am
Exicure Inc. (NASDAQ: XCUR) Rises Sharply in 12/9 Early Trading Session
December 08, 2025 04:30:00 pm
Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting
XCUR Stock Data
$28,126,609
2,071,507
25.09%
15
N/A
Biotechnology & Life Sciences
Healthcare
US
Redwood City
